Gefapixant + Placebo + Naproxen
Phase 2Completed 0 watching 0 views this week⚡ Active
52
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Endometriosis-related Pain
Conditions
Endometriosis-related Pain
Trial Timeline
Sep 11, 2018 → Jun 30, 2020
NCT ID
NCT03654326About Gefapixant + Placebo + Naproxen
Gefapixant + Placebo + Naproxen is a phase 2 stage product being developed by Merck for Endometriosis-related Pain. The current trial status is completed. This product is registered under clinical trial identifier NCT03654326. Target conditions include Endometriosis-related Pain.
Hype Score Breakdown
Clinical
17
Activity
12
Company
10
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03654326 | Phase 2 | Completed |